Vivus Says Ch. 11 Plan Should Be OK'd Despite Opposition
By Rose Krebs ( August 18, 2020, 9:40 PM EDT) -- Biopharmaceutical venture Vivus Inc. told the Delaware bankruptcy court Tuesday its Chapter 11 plan should be approved despite opposition from the federal bankruptcy watchdog and others because it is a "value-maximizing" plan that benefits stakeholders....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.